Effect of combination therapy of eldecalcitol and risedronate on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: an open-label randomized trial

被引：0

作者：

Imanishi, Yasuo ^{[1
]}

Imai, Takumi ^{[2
]}

Fujii, Hisako ^{[3
]}

Aida, Rei ^{[2
]}

Nagata, Yuki ^{[4
]}

Shoji, Tetsuo ^{[4
]}

Kashiwagi, Shinichiro ^{[5
]}

Takashima, Tsutomu ^{[5
]}

Emoto, Masanori ^{[1
]}

机构：

[1] Osaka Metropolitan Univ, Dept Metab Endocrinol & Mol Med, Grad Sch Med, Osaka, Japan

[2] Osaka Metropolitan Univ, Dept Med Stat, Grad Sch Med, Osaka, Japan

[3] Osaka Metropolitan Univ, Dept Hlth & Med Innovat, Grad Sch Med, Osaka, Japan

[4] Osaka Metropolitan Univ, Dept Vasc Med, Grad Sch Med, Osaka, Japan

[5] Osaka Metropolitan Univ, Dept Breast Surg Oncol, Grad Sch Med, Osaka, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SUN-438

引用

页码：358 / 359

页数：2